The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Open accessAbstract
Bone marrow transplantation (BMT) is currently used for the treatment of a variety of neoplastic diseases. However, significant obstacles limiting the efficacy of allogeneic BMT are the occurrence of graft-versus-host disease (GvHD) and tumor relapse. Natural killer (NK) cells exert a variety of immunologic and homoeostatic functions. We examined whether adoptive transfer of activated NK cells of donor type would prevent GvHD after allogeneic BMT in mice. Lethally irradiated C57BL/6 (H-2(b)) mice, were transplanted with MHC incompatible BALB/c (H-2(d)) bone marrow cells and spleen cells and rapidly succumbed to acute GvHD. In contrast, mice that also received activated NK cells of donor type exhibited significant increases in survival. In determining the mechanism by which the NK cells prevented GvHD, mice were concurrently treated with a neutralizing antibodies to the immunosuppressive cytokine TGFbeta. Anti-TGFbeta completely abrogated the protective effects of the activated donor NK cells indicating that TGFbeta plays an important role in the prevention of GvHD by NK cells. We then examined whether activated NK cells of donor type after allogeneic BMT would induce graft-versus-tumor (GvT) effects without GvHD in mice bearing a murine colon adenocarcinoma (MCA-38). 10 d after receiving the tumor, in which the mice had demonstrable lung metastases, recipients received an allogeneic BMT with or without activated NK cells. Administration of activated NK cells resulted in significant GvT effects after allogeneic BMT as evidenced by increases in median survival and fewer lung metastasis. No evidence of GVHD was detected compared with recipients receiving spleen cells alone which also developed fewer lung metastases but in which all had succumbed to GVHD. Thus, our findings suggest that adoptive immunotherapy using activated donor NK cells combined with allogeneic BMT inhibits GvHD and promotes GvT in advanced tumor-bearing mice. These results also suggest that GvT and GvHD can be dissociable phenomena.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Ferrara, J. L. M., & Deeg, H. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241005 · Cited by 1,219
GOLDMAN, J. M., GALE, R. P., HOROWITZ, M. M., BIGGS, J. C., CHAMPLIN, R. E., GLUCKMAN, E., HOFFMANN, R. G., JACOBSEN, S. J., MARMONT, A. M., McGLAVE, P. B., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-6-806 · Cited by 838
T-cell depletion of HLA-identical transplants in leukemia
Marmont, A., Horowitz, M., Gale, R., Sobocinski, K., Ash, R., van Bekkum, D., Champlin, R., Dicke, K., Goldman, J., & Good, R. (1991) · Blood · doi:10.1182/blood.v78.8.2120.2120 · Cited by 745
Armitage, J. O. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301206 · Cited by 601
Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K., & Tamaoki, N. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.1.34 · Cited by 426
Dasch, J. R., Pace, D. R., Waegell, W., Inenaga, D., & Ellingsworth, L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1536 · Cited by 293
Mowat, A. M. (1989) · PubMed Central · Cited by 170
Increasing Utilization of Allogeneic Bone Marrow Transplantation
Bortin, M. M., Horowitz, M. M., & Rimm, A. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-505 · Cited by 123
Interleukin-12 inhibits murine graft-versus-host disease
Sykes, M., Szot, G. L., Nguyen, P., et al. (1995) · Blood · doi:10.1182/blood.v86.6.2429.bloodjournal8662429 · Cited by 119
Levitt, L., Nagler, A., Lee, F., Abrams, J. S., Shatsky, M., & Thompson, D. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115306 · Cited by 38
TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes.
Yamamoto, H., Hirayama, M., Genyea, C., & Kaplan, J. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3842 · Cited by 34
Ghayur, T., Seemayer, T. A., & Lapp, W. S. (1988) · Transplantation · doi:10.1097/00007890-198803000-00017 · Cited by 26
Cited by
Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
Zeiser, R., & Blazar, B. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1609337 · Cited by 1,296
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F., & Velardi, A. (1999) · Blood · doi:10.1182/blood.v94.1.333.413a31_333_339 · Cited by 994
Advances in graft-versus-host disease biology and therapy
Blazar, B. R., Murphy, W. J., & Abedi, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3212 · Cited by 880
Self-citationFunctional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H.-G., & Steinle, A. (2003) · Blood · doi:10.1182/blood-2003-01-0019 · Cited by 541
Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
Welniak, L. A., Blazar, B. R., & Murphy, W. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141606 · Cited by 520
Self-citation
Metadata
- Authors
- Asai, O., Longo, D. L., Tian, Z. G., Hornung, R. L., Taub, D. D., Ruscetti, F. W., & Murphy, W. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-05-01
- Volume
- 101
- Issue
- 9
- Pages
- 1835-1842
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2067308312
- Cited by
- 301
- References
- 13
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.